These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6043735)

  • 1. Experimental evaluation of potential anticancer agents. XXI. Scheduling of arabinosylcytosine to take advantage of its S-phase specificity against leukemia cells.
    Skipper HE; Schabel FM; Wilcox WS
    Cancer Chemother Rep; 1967 Jun; 51(3):125-65. PubMed ID: 6043735
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of repair of DNA single strand breaks in mouse leukemia cells by actinomycin D.
    Lee YC; Bennett LR; Byfield JE
    Biochem Biophys Res Commun; 1972 Nov; 49(3):758-65. PubMed ID: 4674114
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of tryptophan deprivation on L1210 cells in culture.
    Woolley PV; Dion RL; Bono VH
    Cancer Res; 1974 May; 34(5):1010-4. PubMed ID: 4856777
    [No Abstract]   [Full Text] [Related]  

  • 4. Nonspecific inhibition of precursor uptake by alkyl-substituted purines and prednisolone.
    Hill DL; Wingo R
    Chem Biol Interact; 1974 Oct; 9(4):237-44. PubMed ID: 4430013
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of phosphorylated cyclocytidine on deoxyribonucleic acid polymerase.
    Hoshi A; Kanzawa F; Kuretani K; Kanai T; Ichino M
    Biochem Pharmacol; 1973 Nov; 22(22):2829-34. PubMed ID: 4761553
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhanced antitumor effect of cytosine arabinoside given in a schedule dictated by kinetic studies in vivo.
    Young RC; Goldberg D; Schein PS
    Biochem Pharmacol; 1973 Jan; 22(2):277-80. PubMed ID: 4763256
    [No Abstract]   [Full Text] [Related]  

  • 7. Growth rate and cell kill.
    Hryniuk WM; Bertino JR
    Ann N Y Acad Sci; 1971 Nov; 186():330-42. PubMed ID: 5289425
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancement of 1-beta-D-arabinofuranosylcytosine accumulation within L1210 cells and increased cytotoxicity following thymidine exposure.
    Grant S; Lehman C; Cadman E
    Cancer Res; 1980 May; 40(5):1525-31. PubMed ID: 7370990
    [No Abstract]   [Full Text] [Related]  

  • 9. Biochemical and genetic studies of a mutant strain of mouse leukemia L1210 resistant to 1-beta-D-arabinofuranosylcytosine (Cytarabine).
    Bach MK
    Cancer Res; 1969 May; 29(5):1036-44. PubMed ID: 5781095
    [No Abstract]   [Full Text] [Related]  

  • 10. The intracellular concentration dependence of antifolate inhibition of DNA synthesis in L1210 leukemia cells.
    Sirotnak FM; Donsbach RC
    Cancer Res; 1974 Dec; 34(12):332-40. PubMed ID: 4429954
    [No Abstract]   [Full Text] [Related]  

  • 11. X-ray repair replication in L1210 leukemia cells.
    Lee YC; Byfield JE; Bennett LR; Chan YM
    Cancer Res; 1974 Oct; 34(10):2624-33. PubMed ID: 4472428
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolism and selective effects of 1-beta-D-arabinofuranosylcytosine in L1210 and Host tissues in vivo.
    Chou TC; Hutchinson DJ; Schmid FA; Philips FS
    Cancer Res; 1975 Jan; 35(1):225-36. PubMed ID: 1109791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA chain growth during replication of asynchronous L1210 cells. Alkaline elution of large DNA segments from cells lysed on filters.
    Kohn KW; Friedman CA; Ewig RA; Iqbal ZM
    Biochemistry; 1974 Sep; 13(20):4134-9. PubMed ID: 4472075
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of dose interval on the survival of L1210 leukemic mice treated with DNA synthesis inhibitors.
    Neil GL; Homan ER
    Cancer Res; 1973 Apr; 33(4):895-901. PubMed ID: 4696483
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of cell-cycle information in the preparation of drug combinations: results with cytosine arabinoside plus actinomycin D1,2.
    Bhuyan BK; Fraser TJ; Day KJ
    Cancer Treat Rep; 1976 Dec; 60(12):1813-8. PubMed ID: 1036090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and pharmacologic studies with 1- -D-arabinofuranosylcytosine 5'-adamantoate (NSC-117614), a depot form of cytarabine.
    Neil GL; Buskirk HH; Moxley TE; Manak RC; Kuentzel SL; Bhuyan BK
    Biochem Pharmacol; 1971 Dec; 20(12):3295-308. PubMed ID: 5002403
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of neocarzinostatin on DNA synthesis in L1210 cells.
    Sawada H; Tatsumi K; Sasada M; Shirakawa S; Nakamura T
    Cancer Res; 1974 Dec; 34(12):3341-6. PubMed ID: 4473265
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of ribonucleotide reductase, DNA synthesis, and L1210 leukemia by guanazole.
    Brockman RW; Shaddix S; Laster WR; Schabel FM
    Cancer Res; 1970 Sep; 30(9):2358-68. PubMed ID: 5475481
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of macromolecular biosynthesis in cultured L1210 mouse leukemia cells by thalicarpine (NSC 68075).
    Allen LM; Creaven PJ
    Cancer Res; 1973 Dec; 33(12):3112-6. PubMed ID: 4796799
    [No Abstract]   [Full Text] [Related]  

  • 20. Camptothecin effects on DNA synthesis in murine leukemia cells.
    Kessel D; Bosmann HB; Lohr K
    Biochim Biophys Acta; 1972 May; 269(2):210-6. PubMed ID: 5063907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.